Pathology Partners

Inform Diagnostics, originally founded as Pathology Partners in 1996, is a premier national provider of subspecialty anatomic pathology services in the United States. Headquartered in Irving, Texas, the company specializes in gastrointestinal pathology, dermatopathology, urologic pathology, hematopathology, and breast pathology, serving over 1,300 clients and 2,700 physicians. Over its history, the company has operated under the names Caris Diagnostics and Miraca Life Sciences before being rebranded as Inform Diagnostics in 2018. In 2022, the company was acquired by Fulgent Genetics for approximately $170 million, integrating its extensive pathology expertise with Fulgent's advanced genomic testing platform to offer a comprehensive diagnostic suite. The company is recognized for its high-quality diagnostic reports and its team of subspecialty-trained pathologists who provide definitive diagnoses for complex clinical cases.